ClinConnect ClinConnect Logo
Search / Trial NCT05520268

Efficacy of Music Therapy and Digital Music Rehabilitation in Dementia

Launched by UNIVERSITY OF HELSINKI · Aug 26, 2022

Trial Information

Current as of October 26, 2025

Recruiting

Keywords

Music Therapy Music Based Rehabilitation Digital Intervention Cognitive Functioning Memory Emotion Mood Quality Of Life Electroencephalography Magnetic Resonance Imaging

ClinConnect Summary

This clinical trial is investigating how effective music therapy and digital music rehabilitation can be for people with dementia. The study aims to see if these types of music programs can help improve the well-being of patients living at home or in care homes. It is currently looking for participants who are 60 years or older, speak Finnish, and have been diagnosed with mild to severe dementia. They should also be in stable health and able to participate in the activities.

If you or a loved one is eligible and decides to join, you can expect to engage in music sessions designed to improve mood and cognitive function. The trial will carefully assess how these music therapies impact your quality of life. It’s important to note that individuals with serious mental health issues or significant hearing or vision problems are not eligible to participate. This study could provide valuable insights into how music can support those living with dementia.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosed dementia (according to International Classification of Diseases \[ICD\] criteria), which is mild \[Clinical Dementia Rating (CDR) score: 0.5-1, Global Deterioration Scale (GDS) score: 3-4\], moderate (CDR: 2, GDS: 4-6), or severe (CDR: 3, GDS: 6-7) dementia
  • Age ≥ 60 years
  • Finnish-speaking (or bilingual; the study is performed in Finnish)
  • Stable physical and somatic condition (no major changes in psychotropic medication during the last 3 months)
  • Physically and cognitively able to take part in the intervention and assessments.
  • Exclusion Criteria:
  • Prior severe psychiatric illness or substance abuse
  • Major hearing or visual impairment

About University Of Helsinki

The University of Helsinki, a prestigious institution in Finland, is dedicated to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university engages in cutting-edge studies that aim to improve patient outcomes and contribute to the global knowledge base in medicine. Its commitment to ethical standards and rigorous methodology ensures the integrity and reliability of its clinical research initiatives, making it a key player in the development of novel therapeutic strategies and healthcare solutions.

Locations

Helsinki, Finland

Helsinki, Finland

Patients applied

0 patients applied

Trial Officials

Teppo Särkämö, PhD

Principal Investigator

University of Helsinki

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials